Updates are available Correction dated 2021-11-24
Click to view Correction: https://doi.org/10.1007/s00134-021-06588-8
-
Authors
Rouzé, Anahita
Martin-Loeches, Ignacio
Povoa, Pedro
Makris, Demosthenes
Artigas, Antonio
Bouchereau, Mathilde
Lambiotte, Fabien
Metzelard, Matthieu
Cuchet, Pierre
Boulle Geronimi, Claire
Labruyere, Marie
Tamion, Fabienne
Nyunga, Martine
Luyt, Charles-Edouard
Labreuche, Julien
Pouly, Olivier
Bardin, Justine
Saade, Anastasia
Asfar, Pierre
Baudel, Jean-Luc
Beurton, Alexandra
Garot, Denis
Ioannidou, Iliana
Kreitmann, Louis
Llitjos, Jean-François
Magira, Eleni
Mégarbane, Bruno
Meguerditchian, David
Moglia, Edgar
Mekontso-Dessap, Armand
Reignier, Jean
Turpin, Matthieu
Pierre, Alexandre
Plantefeve, Gaetan
Vinsonneau, Christophe
Floch, Pierre-Edouard
Weiss, Nicolas
Ceccato, Adrian
Torres, Antoni
Duhamel, Alain
Nseir, Saad https://orcid.org/0000-0002-7618-0357
,
Favory, Raphaël
Preau, Sébastien
Jourdain, Mercé
Poissy, Julien
Bouras, Chaouki
Saint Leger, Piehr
Fodil, Hanane
Aptel, François
Van Der Linden, Thierry
Thille, Arnaud W.
Azoulay, Elie
Pène, Frédéric
Razazi, Keyvan
Bagate, François
Contou, Damien
Voiriot, Guillaume
Thevenin, Didier
Guidet, Bertrand
Le Guennec, Loïc
Kouatchet, Achille
Ehrmann, Stephan
Brunin, Guillaume
Morawiec, Elise
Boyer, Alexandre
Argaud, Laurent
Voicu, Sebastian
Nieszkowska, Ania
Kowalski, Benjamin
Goma, Gemma
Diaz, Emilio
Morales, Luis
Tsolaki, Vassiliki
Gtavriilidis, George
Mentzelopoulos, Spyros D.
Nora, David
Boyd, Sean
Coelho, Luis
Maizel, Julien
Du Cheyron, Damien
Imouloudene, Mehdi
Quenot, Jean-Pierre
Guilbert, Arnaud
Cilloniz, Catia
-
Funding
Funding for this research was provided by:
French Government « Programme Investissement d’Avenir » (I-SITE ULNE) managed by the Agence Nationale de la Recherche (coVAPid project)
- License Information
-
More Information
Article History
Received: 13 August 2020
Accepted: 11 November 2020
First Online: 3 January 2021
Change Date: 24 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-021-06588-8
Compliance with ethical standards
:
: AR received personal fees from MaatPharma, IML received personal fees from MSD, and Gilead. AA received personal fees from Lilly Foundation, and grants from Grifols and Fischer & Paykel. CEL received personal fees from Bayer, Merck, Aerogen, Biomérieux, ThermoFischer Brahms, and Carmat. NW received personal fees from MedDay pharmaceuticals. SN received personal fees from MSD, Bio Rad, BioMérieux, Gilead, and Pfizer. All other authors declare no competing interests.
: All data needed to evaluate the conclusions in this Article are present and tabulated in the main text or the appendix. This article is the result of an original retrospective cohort. For individual de-identified raw data that underlie the results reported in this article, please contact the corresponding author.
Free to read: This content has been made available to all.
